In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1857 News Items found
Light micrograph of white blood cells from a patient with acute myeloid leukemia.
In the Lab
New Drug Developed at MSK Starves Acute Myeloid Leukemia of a Signaling Fix

An innovative collaboration between basic scientists and clinical researchers has led to a promising new drug for AML.
This cross section of a mouse intestine shows dividing cells (stained white) in the epithelial layer of the intestine, which lines the organ. These proliferating cells help restore intestinal tissue after damage from graft-versus-host disease (GVHD).
In the Lab
Immune System Molecule Could Become New Treatment for Graft-Versus-Host Disease

Scientists are using a molecule from the immune system to combat this serious complication in a new way.
Dr. Charles Sawyers, Vice President Joe Biden, and Dr. José Baselga.
In the News
Can America Cure Cancer?

During his State of the Union address, President Obama proposed a “moonshot” to cure cancer. Following that, MSK physicians attended a roundtable discussion at the World Economic Forum in Davos-Klosters, Switzerland to discuss progress on what a cure might look like.
Montage of beer, reproducing cells, and building blocks
Feature
License to Build: New Theory of Cancer Puts Metabolism at Center

MSK researchers are rethinking the relationship between metabolism and cancer, and finding insights in some unexpected places. Your beer glass, for example.
MSK Experts Weigh in on Mammography Debate

Many women are confused by conflicting guidelines on breast screening. And the latest recommendations made by the USPSTF are adding to that confusion. MSK experts are available to answer questions and explain what MSK recommends and why it is not altering its guidelines. To schedule an interview with a member of MSK’s breast cancer leadership team, please contact Nicole McNamara at [email protected].
Charles Rudin and David Jones, leaders of the Druckenmiller Center
In the Clinic
MSK’s New Fiona and Stanley Druckenmiller Center for Lung Cancer Research Takes on Biggest Cancer Killer

The new Fiona and Stanley Druckenmiller Center for Lung Cancer Research brings together MSK physicians and scientists in an intensive, multidisciplinary effort against the number-one cause of death from cancer in the nation.
Illustration of DNA strands
In the Lab
Project GENIE Aims to Make Sense of Vast Amounts of Genomic Data

A multi-institutional effort led by MSK’s Charles Sawyers is seeking to interpret information about the genetic causes of cancer.
Microscopic image of spherical cluster of cells, most of them pink cells with a smaller number of blue ones.
Feature
Three Compelling Cancer Advances from 2015

MSK researchers moved cancer science ahead in 2015 with landmark discoveries that suggest new treatment strategies and shed light on how the disease progresses.
Consuming alcohol is dangerous when you have liver cancer or cirrhosis.
Ask the Expert
Should a Person with Liver Cancer Stop Drinking Alcohol?

Learn why medical oncologist Ghassan Abou-Alfa counsels his patients with liver cancer to stop drinking.
Researchers at MSK have devised a technique, based on machine learning, that can predict the DNA binding preferences of a protein called a transcription factor.
In the Lab
A Netflix-Inspired Approach to Understanding Biology and Medicine

Computers currently help us choose our favorite movies, books, and TV shows. Will personalized medicines be next?